Stephen Saad. Picture: Bloomberg/Waldo Swiegers
Stephen Saad. Picture: Bloomberg/Waldo Swiegers

Aspen Pharmacare has reached a preliminary agreement with Johnson & Johnson to manufacture the US company’s Covid-19 vaccine should its clinical trials prove successful. The production will be done at Aspen’s Port Elizabeth facility.

Business Day TV spoke to CEO Stephen Saad for more detail on the agreement.

Aspen Pharmacare CEO Stephen Saad talks to Business Day TV about the preliminary agreement with Johnson & Johnson to manufacture the US company's Covid-19 vaccine

Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.